News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
268,416 Results
Type
Article (14298)
Company Profile (281)
Press Release (253837)
Multimedia
Podcasts (48)
Webinars (7)
Section
Business (79629)
Career Advice (153)
Deals (13250)
Drug Delivery (35)
Drug Development (50539)
Employer Resources (31)
FDA (5737)
Job Trends (5142)
News (144679)
Policy (10111)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (4)
2024 Biotech Bay Standard (10)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (7)
2024 Genetown Standard (6)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (3)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (3)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (915)
Accelerated approval (2)
Adcomms (12)
Allergies (51)
Alliances (21702)
ALS (64)
Alzheimer's disease (849)
Antibody-drug conjugate (ADC) (100)
Approvals (5766)
Artificial intelligence (123)
Autoimmune disease (18)
Automation (5)
Bankruptcy (105)
Best Places to Work (4565)
BIOSECURE Act (6)
Biosimilars (46)
Biotechnology (232)
Bladder cancer (58)
Brain cancer (20)
Breast cancer (155)
Cancer (1476)
Cardiovascular disease (116)
Career advice (133)
Career pathing (2)
CAR-T (116)
Cell therapy (328)
Cervical cancer (8)
Clinical research (41146)
Collaboration (544)
Compensation (258)
Complete response letters (13)
COVID-19 (1036)
CRISPR (41)
C-suite (163)
Cystic fibrosis (76)
Data (1515)
Denatured (11)
Depression (29)
Diabetes (138)
Diagnostics (1299)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (85)
Drug pricing (28)
Drug shortages (3)
Duchenne muscular dystrophy (90)
Earnings (29850)
Editorial (18)
Employer branding (4)
Employer resources (29)
Events (48606)
Executive appointments (459)
FDA (6437)
Featured Employer (30)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (498)
Gene editing (96)
Generative AI (10)
Gene therapy (252)
GLP-1 (365)
Government (1102)
Grass and pollen (2)
Guidances (22)
Healthcare (6600)
Huntington's disease (22)
IgA nephropathy (25)
Immunology and inflammation (91)
Indications (20)
Infectious disease (1101)
Inflammatory bowel disease (114)
Inflation Reduction Act (8)
Influenza (19)
Intellectual property (67)
Interviews (17)
IPO (7283)
IRA (11)
Job creations (863)
Job search strategy (127)
Kidney cancer (7)
Labor market (5)
Layoffs (209)
Leadership (3)
Legal (1397)
Liver cancer (33)
Lung cancer (205)
Lymphoma (100)
Machine learning (3)
Management (7)
Manufacturing (138)
MASH (53)
Medical device (2601)
Medtech (2602)
Mergers & acquisitions (6300)
Metabolic disorders (389)
Multiple sclerosis (53)
NASH (13)
Neurodegenerative disease (68)
Neuropsychiatric disorders (25)
Neuroscience (1256)
NextGen: Class of 2025 (2018)
Non-profit (854)
Northern California (1697)
Now hiring (22)
Obesity (193)
Opinion (102)
Ovarian cancer (63)
Pain (43)
Pancreatic cancer (56)
Parkinson's disease (121)
Partnered (8)
Patents (129)
Patient recruitment (76)
Peanut (35)
People (25670)
Pharmaceutical (47)
Pharmacy benefit managers (5)
Phase I (14515)
Phase II (19126)
Phase III (12116)
Pipeline (806)
Policy (44)
Postmarket research (861)
Preclinical (6137)
Press Release (30)
Prostate cancer (62)
Psychedelics (35)
Radiopharmaceuticals (213)
Rare diseases (292)
Real estate (1424)
Recruiting (12)
Regulatory (8685)
Reports (15)
Research institute (938)
Resumes & cover letters (17)
Rett syndrome (4)
RNA editing (5)
RSV (10)
Schizophrenia (59)
Series A (98)
Series B (63)
Service/supplier (1)
Sickle cell disease (40)
Southern California (1485)
Special edition (11)
Spinal muscular atrophy (117)
Sponsored (12)
Startups (1975)
State (1)
Stomach cancer (4)
Supply chain (23)
Tariffs (8)
The Weekly (36)
United States (13215)
Vaccines (214)
Venture capitalists (32)
Weight loss (109)
Women's health (15)
Worklife (2)
Date
Today (121)
Last 7 days (521)
Last 30 days (1575)
Last 365 days (19608)
2025 (6208)
2024 (20572)
2023 (22430)
2022 (26853)
2021 (27844)
2020 (23389)
2019 (16266)
2018 (11762)
2017 (13759)
2016 (11855)
2015 (14366)
2014 (10405)
2013 (7498)
2012 (7558)
2011 (7631)
2010 (7442)
Location
Africa (148)
Alabama (42)
Alaska (2)
Arizona (53)
Arkansas (5)
Asia (17324)
Australia (2952)
California (3844)
Canada (1141)
China (358)
Colorado (149)
Connecticut (151)
Delaware (102)
Europe (37305)
Florida (463)
Georgia (115)
Idaho (16)
Illinois (234)
India (10)
Indiana (91)
Iowa (2)
Japan (73)
Kansas (62)
Kentucky (5)
Louisiana (3)
Maine (11)
Maryland (472)
Massachusetts (3069)
Michigan (70)
Minnesota (145)
Mississippi (1)
Missouri (24)
Montana (14)
Nebraska (4)
Nevada (17)
New Hampshire (14)
New Jersey (961)
New Mexico (12)
New York (1039)
North Carolina (552)
North Dakota (5)
Northern California (1697)
Ohio (112)
Oklahoma (9)
Oregon (21)
Pennsylvania (738)
Puerto Rico (6)
Rhode Island (19)
South America (209)
South Carolina (4)
Southern California (1485)
Tennessee (25)
Texas (446)
Utah (53)
Virginia (78)
Washington D.C. (30)
Washington State (351)
Wisconsin (15)
268,416 Results for "rani therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Rani Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results
March 26, 2025
·
1 min read
Press Releases
Rani Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results; Provides Corporate Update
April 1, 2025
·
12 min read
Business
Rani Therapeutics Announces Partnership with ProGen on Development of Oral Obesity Treatment
Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”)(Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced that it has entered into a definitive agreement with ProGen Co., Ltd.
June 24, 2024
·
7 min read
Press Releases
Rani Therapeutics Announces Preclinical Data Demonstrating Successful Oral Delivery of Semaglutide via RaniPill® HC
February 5, 2025
·
7 min read
Business
Rani Therapeutics Reports First Quarter 2024 Financial Results; Provides Corporate Update
Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today reported financial results for the quarter ended March 31, 2024 and provided a corporate update.
May 6, 2024
·
7 min read
Press Releases
Rani Therapeutics to Participate in Upcoming Investor Conferences
November 8, 2024
·
1 min read
Biotech Bay
Rani Therapeutics to Participate in May 2024 Investor Conferences
Rani Therapeutics Holdings, Inc., a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, announced that the Company will participate in two upcoming investor conferences in May 2024.
May 14, 2024
·
1 min read
Press Releases
Rani Therapeutics Announces Preclinical Data Demonstrating Bioequivalence of RT-114, a GLP-1/GLP-2 Dual Agonist (PG-102) Delivered Orally via the RaniPill® Capsule, to Subcutaneously Administered PG-102
March 26, 2025
·
8 min read
Business
Rani Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results; Provides Corporate Update
Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today reported financial results for the quarter and full year ended December 31, 2023 and provided a corporate update.
March 20, 2024
·
11 min read
Press Releases
Rani Therapeutics Reports Third Quarter 2024 Financial Results; Provides Corporate Update
November 14, 2024
·
8 min read
1 of 26,842
Next
